Functional genomic landscape of acute myeloid leukaemia

Jeffrey Tyner, Cristina E. Tognon, Daniel Bottomly, +85

Nature

Hematological MalignancyChromatinFunctional GenomicsMixed-phenotype Acute LeukemiaGenetics +5

Integrative analysis of drug response and clinical outcome in acute myeloid leukemia

Daniel Bottomly, Nicola Long, Anna Reister Schultz, +91

Cancer Cell

CSF1R inhibitors exhibit antitumor activity in acute myeloid leukemia by blocking paracrine signals from support cells

David K. Edwards, Kevin Watanabe‐Smith, Angela Rofelty, +14

Blood

Reversible suppression of T cell function in the bone marrow microenvironment of acute myeloid leukemia

Adam J. Lamble, Yoko Kosaka, Ted Laderas, +19

Proceedings of the National Academy of Sciences

Identification and prioritization of myeloid malignancy germline variants in a large cohort of adult patients with AML

Fei Yang, Nicola Long, Tauangtham Anekpuritanang, +22

Blood

Genomic landscape of neutrophilic leukemias of ambiguous diagnosis

Haijiao Zhang, Beth Wilmot, Daniel Bottomly, +29

Blood

Comparison and validation of the 2022 European LeukemiaNet guidelines in acute myeloid leukemia

Curtis A. Lachowiez, Nicola Long, Jennifer N. Saultz, +15

Blood Advances

Mixed-phenotype Acute LeukemiaPathologyLogistic AnalysisMyeloid NeoplasiaHematological Malignancy +14

Integrative Analysis of Drug Response and Clinical Outcome in Acute Myeloid Leukemia

Daniel Bottomly, Nicola Long, Anna Reister Schultz, +90

SSRN Electronic Journal

Two myeloid leukemia cases with rare <i>FLT3</i> fusions

Haijiao Zhang, Aleksandra Paliga, Stephen Moore, +4

Molecular Case Studies

Simultaneous kinase inhibition with ibrutinib and BCL2 inhibition with venetoclax offers a therapeutic strategy for acute myeloid leukemia

Christopher A. Eide, Stephen E. Kurtz, Andy Kaempf, +8

Leukemia

Hematological MalignancyOncologySimultaneous Kinase InhibitionAcute Myeloid LeukemiaMedicine +10